Envonalkib | m-entrepreneurship.com

Product Name :
Envonalkib

Search keywords :
HGF

drugId :
null

Target Vo:
Anaplastic lymphoma kinase

Target Vo Short Name :
ALK

Moa_Name:
Anaplastic lymphoma kinase inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2024

Origin Company_Name :
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd

Active Company_Name :
Beijing Centaurus Biopharma Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Liver Arginase Antibody
AKT1 Antibody (YA834)
GFAP Antibody (YA416): GFAP Antibody (YA416) is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to GFAP. It can be used for WB,IHC-P,IP,IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts